MET and breast cancer: Although properly understanding the involvement of c-Met in the progression of BC requires further research, several studies have shown that c-Met overexpression occurs in localized tumors, suggesting that targeted therapies against c-Met pathway might play a role in avoiding the progression of early-stage disease [146].